The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Open accessAbstract
Non-alcoholic fatty liver disease (NAFLD) has become one of the most common forms of chronic liver disease worldwide and its prevalence is expected to continue rising. NAFLD has traditionally been considered a consequence of metabolic syndrome (MetS). However, the link between NAFLD and MetS components, especially type 2 diabetes mellitus (T2DM), hypertension (HTN), and cardiovascular disease (CVD) is more complex than previously thought. Indeed, the adverse effects of NAFLD extend far beyond the liver, with a large body of clinical evidence now suggesting that NAFLD may precede and/or promote the development of T2DM, HTN and atherosclerosis/CVD. The risk of developing these cardiometabolic diseases parallels the underlying severity of NAFLD. Accumulating evidence suggests that the presence and severity of NAFLD is associated with an increased risk of incident T2DM and HTN. Moreover, long-term prospective studies indicate that the presence and severity of NAFLD independently predicts fatal and nonfatal CVD events. In this review, we critically discuss the rapidly expanding body of clinical evidence that supports the existence of a bi-directional relationship between NAFLD and various components of MetS, particularly T2DM and HTN, as well as the current knowledge regarding a strong association between NAFLD and CVD morbidity and mortality. Finally, we discuss the most updated putative biological mechanisms through which NAFLD may contribute to the development of HTN, T2DM and CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhou, Y. J., Li, Y. Y., Nie, Y. Q., Huang, C., & Cao, C. Y. (2011) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2011.00571.x · Cited by 93
Retracted(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Self-citationAngulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Self-citationSingh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.014 · Cited by 1,748
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Self-citationThe pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Samuel, V. T., & Shulman, G. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci77812 · Cited by 1,484
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Targher, G., Byrne, C. D., Lonardo, A., Zoppini, G., & Barbui, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.013 · Cited by 1,424
Self-citationThe economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Younossi, Z. M., Blissett, D., Blissett, R., Henry, L., Stepanova, M., Younossi, Y., Racila, A., Hunt, S., & Beckerman, R. (2016) · Hepatology · doi:10.1002/hep.28785 · Cited by 1,285
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
Yki-Järvinen, H. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70032-4 · Cited by 1,259
Kim, K.-A., Gu, W., Lee, I.-A., Joh, E.-H., & Kim, D.-H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047713 · Cited by 1,176
Adams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017) · Gut · doi:10.1136/gutjnl-2017-313884 · Cited by 1,174
Self-citationAortic Stiffness, Blood Pressure Progression, and Incident Hypertension
Kaess, B. M., Rong, J., Larson, M. G., Hamburg, N. M., Vita, J. A., Levy, D., Benjamin, E. J., Vasan, R. S., & Mitchell, G. F. (2012) · JAMA · doi:10.1001/2012.jama.10503 · Cited by 1,086
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
Hamaguchi, M., Kojima, T., Takeda, N., Nakagawa, T., Taniguchi, H., Fujii, K., Omatsu, T., Nakajima, T., Sarui, H., Shimazaki, M., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-10-200511150-00009 · Cited by 1,062
McPherson, S., Hardy, T., Henderson, E., Burt, A. D., Day, C. P., & Anstee, Q. M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.034 · Cited by 1,060
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Tessari, R., Zenari, L., Day, C., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc06-2247 · Cited by 992
Self-citationMichelotti, G. A., Machado, M. V., & Diehl, A. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.183 · Cited by 974
Rubino, F., Forgione, A., Cummings, D. E., Vix, M., Gnuli, D., Mingrone, G., Castagneto, M., & Marescaux, J. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000224726.61448.1b · Cited by 928
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Baffy, G., Brunt, E. M., & Caldwell, S. H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.027 · Cited by 858
Ablation of CD11c-Positive Cells Normalizes Insulin Sensitivity in Obese Insulin Resistant Animals
Patsouris, D., Li, P.-P., Thapar, D., Chapman, J., Olefsky, J. M., & Neels, J. G. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.015 · Cited by 804 · cited 3×
“Although stored hepatic triglycerides are not thought to directly impair insulin action, hepatic ceramides and diacyl-glycerols (DAGs) have emerged as the two best-studied putative mediators of lipid-induced hepatic IR.”
BackgroundInfluentialKim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology · doi:10.1002/hep.26156 · Cited by 772
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
Marengo, A., Rosso, C., & Bugianesi, E. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-090514-013832 · Cited by 755
Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up
Söderberg, C., Stål, P., Askling, J., Glaumann, H., Lindberg, G., Marmur, J., & Hultcrantz, R. (2010) · Hepatology · doi:10.1002/hep.23314 · Cited by 754
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
Rafiq, N., Bai, C., Fang, Y., Srishord, M., McCullough, A., Gramlich, T., & Younossi, Z. M. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.11.005 · Cited by 729
Musso, G., Gambino, R., Tabibian, J. H., Ekstedt, M., Kechagias, S., Hamaguchi, M., Hultcrantz, R., Hagström, H., Yoon, S. K., Charatcharoenwitthaya, P., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001680 · Cited by 720
Ballestri, S., Zona, S., Targher, G., Romagnoli, D., Baldelli, E., Nascimbeni, F., Roverato, A., Guaraldi, G., & Lonardo, A. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13264 · Cited by 717
Self-citationDiabetes and hypertension: the bad companions
Ferrannini, E., & Cushman, W. C. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60987-8 · Cited by 695
Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P., & Loria, P. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.09.020 · Cited by 685
Self-citationThe plasma lipidomic signature of nonalcoholic steatohepatitis
Puri, P., Wiest, M. M., Cheung, O., Mirshahi, F., Sargeant, C., Min, H., Contos, M. J., Sterling, R. K., Fuchs, M., Zhou, H., et al. (2009) · Hepatology · doi:10.1002/hep.23229 · Cited by 655
Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia
Moreira, A. P. B., Texeira, T. F. S., Ferreira, A. B., do Carmo Gouveia Peluzio, M., & de Cássia Gonçalves Alfenas, R. (2012) · British Journal of Nutrition · doi:10.1017/s0007114512001213 · Cited by 655
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†
Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E., Magalotti, D., Vanni, E., Zoli, M., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20781 · Cited by 629
Ceramides – Lipotoxic Inducers of Metabolic Disorders
Chaurasia, B., & Summers, S. A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.07.006 · Cited by 616
Benjamin, E. J., Larson, M. G., Keyes, M. J., Mitchell, G. F., Vasan, R. S., Keaney, J. F., Lehman, B. T., Fan, S., Osypiuk, E., & Vita, J. A. (2004) · Circulation · doi:10.1161/01.cir.0000112565.60887.1e · Cited by 607
Local and systemic effects of the multifaceted epicardial adipose tissue depot
Iacobellis, G. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.58 · Cited by 605
Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
Kumashiro, N., Erion, D. M., Zhang, D., Kahn, M., Beddow, S. A., Chu, X., Still, C. D., Gerhard, G. S., Han, X., Dziura, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113359108 · Cited by 585
Targher, G., Bertolini, L., Rodella, S., Tessari, R., Zenari, L., Lippi, G., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc07-0349 · Cited by 579
Self-citationO’Brien, K. D., McDonald, T. O., Chait, A., Allen, M. D., & Alpers, C. E. (1996) · Circulation · doi:10.1161/01.cir.93.4.672 · Cited by 573
Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
Hamaguchi, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i10.1579 · Cited by 542
Long term prognosis of fatty liver: risk of chronic liver disease and death
Dam-Larsen, S., Franzmann, M., Andersen, I. B., Christoffersen, P., Jensen, L. B., Sørensen, T. I. A., Becker, U., & Bendtsen, F. (2004) · Gut · doi:10.1136/gut.2003.019984 · Cited by 508
Portillo-Sanchez, P., Bril, F., Maximos, M., Lomonaco, R., Biernacki, D., Orsak, B., Subbarayan, S., Webb, A., Hecht, J., & Cusi, K. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1966 · Cited by 503
From the metabolic syndrome to NAFLD or vice versa?
Vanni, E., Bugianesi, E., Kotronen, A., De Minicis, S., Yki-Järvinen, H., & Svegliati-Baroni, G. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.016 · Cited by 497
Kwok, R., Choi, K. C., Wong, G. L.-H., Zhang, Y., Chan, H. L.-Y., Luk, A. O.-Y., Shu, S. S.-T., Chan, A. W.-H., Yeung, M.-W., Chan, J. C.-N., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309265 · Cited by 480
Pathophysiological role of leptin in obesity-related hypertension
Aizawa-Abe, M., Ogawa, Y., Masuzaki, H., Ebihara, K., Satoh, N., Iwai, H., Matsuoka, N., Hayashi, T., Hosoda, K., Inoue, G., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8341 · Cited by 477
The impact of insulin resistance on the kidney and vasculature
Artunc, F., Schleicher, E., Weigert, C., Fritsche, A., Stefan, N., & Häring, H.-U. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.145 · Cited by 462
Luukkonen, P. K., Zhou, Y., Sädevirta, S., Leivonen, M., Arola, J., Orešič, M., Hyötyläinen, T., & Yki-Järvinen, H. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.002 · Cited by 461
The Role of Monocytes in Angiogenesis and Atherosclerosis
Jaipersad, A. S., Lip, G. Y. H., Silverman, S., & Shantsila, E. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.019 · Cited by 451
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
Lonardo, A., Bellentani, S., Argo, C. K., Ballestri, S., Byrne, C. D., Caldwell, S. H., Cortez-Pinto, H., Grieco, A., Machado, M. V., Miele, L., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.08.004 · Cited by 444
Self-citationImmunological Goings-on in Visceral Adipose Tissue
Mathis, D. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.008 · Cited by 437
Vascular Endothelial Function and Hypertension: Insights and Directions
Dharmashankar, K., & Widlansky, M. E. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0150-2 · Cited by 424
Adams, L. A., Waters, O. R., Knuiman, M. W., Elliott, R. R., & Olynyk, J. K. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.67 · Cited by 413
YOSHIJI, H., KURIYAMA, S., YOSHII, J., IKENAKA, Y., NOGUCHI, R., NAKATANI, T., TSUJINOUE, H., & FUKUI, H. (2001) · Hepatology · doi:10.1053/jhep.20001.28231 · Cited by 397
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
Lazo, M., Hernaez, R., Bonekamp, S., Kamel, I. R., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · BMJ · doi:10.1136/bmj.d6891 · Cited by 395
Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis: A Case–Control Study
Brea, A., Mosquera, D., Martín, E., Arizti, A., Cordero, J. L., & Ros, E. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160613.57985.18 · Cited by 387
Apovian, C. M., Bigornia, S., Mott, M., Meyers, M. R., Ulloor, J., Gagua, M., McDonnell, M., Hess, D., Joseph, L., & Gokce, N. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.170316 · Cited by 386
Hong, H. C., Hwang, S. Y., Choi, H. Y., Yoo, H. J., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., Choi, D. S., & Choi, K. M. (2014) · Hepatology · doi:10.1002/hep.26716 · Cited by 385
Brunkwall, L., & Orho-Melander, M. (2017) · Diabetologia · doi:10.1007/s00125-017-4278-3 · Cited by 355
Stepanova, M., & Younossi, Z. M. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.12.039 · Cited by 352
Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis
Van Rooyen, D. M., Larter, C. Z., Haigh, W. G., Yeh, M. M., Ioannou, G., Kuver, R., Lee, S. P., Teoh, N. C., & Farrell, G. C. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.040 · Cited by 345
Independent Predictors of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Hossain, N., Afendy, A., Stepanova, M., Nader, F., Srishord, M., Rafiq, N., Goodman, Z., & Younossi, Z. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.06.007 · Cited by 342
Lee, Y.-H., Jung, K. S., Kim, S. U., Yoon, H.-J., Yun, Y. J., Lee, B.-W., Kang, E. S., Han, K.-H., Lee, H. C., & Cha, B.-S. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.051 · Cited by 340
Lee, Y., Kim, S. U., Song, K., Park, J. Y., Kim, D. Y., Ahn, S. H., Lee, B., Kang, E. S., Cha, B., & Han, K. (2016) · Hepatology · doi:10.1002/hep.28376 · Cited by 340
Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study
Dunn, W., Xu, R., Wingard, D. L., Rogers, C., Angulo, P., Younossi, Z. M., & Schwimmer, J. B. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02034.x · Cited by 325
Singh, S., Singh, P. P., Singh, A. G., Murad, M. H., & Sanchez, W. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.5 · Cited by 320
Wu, S., Wu, F., Ding, Y., Hou, J., Bi, J., & Zhang, Z. (2016) · Scientific Reports · doi:10.1038/srep33386 · Cited by 318
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease
Targher, G., & Byrne, C. D. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.16 · Cited by 309
Self-citationAISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
Lonardo, A., Nascimbeni, F., Targher, G., Bernardi, M., Bonino, F., Bugianesi, E., Casini, A., Gastaldelli, A., Marchesini, G., Marra, F., et al. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.01.147 · Cited by 306
Self-citationVanWagner, L. B., Wilcox, J. E., Colangelo, L. A., Lloyd‐Jones, D. M., Carr, J. J., Lima, J. A., Lewis, C. E., Rinella, M. E., & Shah, S. J. (2015) · Hepatology · doi:10.1002/hep.27869 · Cited by 305
Kantartzis, K., Peter, A., Machicao, F., Machann, J., Wagner, S., Königsrainer, I., Königsrainer, A., Schick, F., Fritsche, A., Häring, H.-U., et al. (2009) · Diabetes · doi:10.2337/db09-0279 · Cited by 303
Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia.
Kwon, H. M., Sangiorgi, G., Ritman, E. L., McKenna, C., Holmes, D. R., Schwartz, R. S., & Lerman, A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1568 · Cited by 295
Noninvasive evaluation of NAFLD
Castera, L., Vilgrain, V., & Angulo, P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.175 · Cited by 273
Ballestri, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1724 · Cited by 262
Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism
Meex, R. C., Hoy, A. J., Morris, A., Brown, R. D., Lo, J. C. Y., Burke, M., Goode, R. J. A., Kingwell, B. A., Kraakman, M. J., Febbraio, M. A., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.023 · Cited by 255
Hepatic steatosis is associated with an increased risk of carotid atherosclerosis
Völzke, H. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i12.1848 · Cited by 248
Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD
Pasarín, M., La Mura, V., Gracia-Sancho, J., García-Calderó, H., Rodríguez-Vilarrupla, A., García-Pagán, J. C., Bosch, J., & Abraldes, J. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032785 · Cited by 247
Haring, R., Wallaschofski, H., Nauck, M., Dörr, M., Baumeister, S. E., & Völzke, H. (2009) · Hepatology · doi:10.1002/hep.23135 · Cited by 245
Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance
Petersen, M. C., Madiraju, A. K., Gassaway, B. M., Marcel, M., Nasiri, A. R., Butrico, G., Marcucci, M. J., Zhang, D., Abulizi, A., Zhang, X.-M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86013 · Cited by 240
Nonalcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-Aged Japanese Men
Shibata, M., Kihara, Y., Taguchi, M., Tashiro, M., & Otsuki, M. (2007) · Diabetes Care · doi:10.2337/dc07-0792 · Cited by 238
Non-alcoholic fatty liver disease and risk of cardiovascular disease
Lonardo, A., Sookoian, S., Pirola, C. J., & Targher, G. (2016) · Metabolism · doi:10.1016/j.metabol.2015.09.017 · Cited by 236
Self-citationTargher, G., Bertolini, L., Padovani, R., Rodella, S., Zoppini, G., Pichiri, I., Sorgato, C., Zenari, L., & Bonora, E. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.030 · Cited by 235
Self-citationBi-directional analysis between fatty liver and cardiovascular disease risk factors
Ma, J., Hwang, S.-J., Pedley, A., Massaro, J. M., Hoffmann, U., Chung, R. T., Benjamin, E. J., Levy, D., Fox, C. S., & Long, M. T. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.022 · Cited by 234
Price, P. A., & Lim, J. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300744200 · Cited by 218
Sung, K.-C., Jeong, W.-S., Wild, S. H., & Byrne, C. D. (2012) · Diabetes Care · doi:10.2337/dc11-1853 · Cited by 218
Role of leptin in blood pressure regulation and arterial hypertension
Bełtowski, J. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000222743.06584.66 · Cited by 215
Non‐invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE
Doycheva, I., Cui, J., Nguyen, P., Costa, E. A., Hooker, J., Hofflich, H., Bettencourt, R., Brouha, S., Sirlin, C. B., & Loomba, R. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13405 · Cited by 210
Carotid Artery Intima-media Thickness in Nonalcoholic Fatty Liver Disease
Fracanzani, A. L., Burdick, L., Raselli, S., Pedotti, P., Grigore, L., Santorelli, G., Valenti, L., Maraschi, A., Catapano, A., & Fargion, S. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.08.041 · Cited by 209
Al Rifai, M., Silverman, M. G., Nasir, K., Budoff, M. J., Blankstein, R., Szklo, M., Katz, R., Blumenthal, R. S., & Blaha, M. J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.02.011 · Cited by 208
Bazick, J., Donithan, M., Neuschwander-Tetri, B. A., Kleiner, D., Brunt, E. M., Wilson, L., Doo, E., Lavine, J., Tonascia, J., & Loomba, R. (2015) · Diabetes Care · doi:10.2337/dc14-1239 · Cited by 206
Null Mutation in Hormone-Sensitive Lipase Gene and Risk of Type 2 Diabetes
Albert, J. S., Yerges-Armstrong, L. M., Horenstein, R. B., Pollin, T. I., Sreenivasan, U. T., Chai, S., Blaner, W. S., Snitker, S., O'Connell, J. R., Gong, D.-W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315496 · Cited by 199
Gan, L. T., Van Rooyen, D. M., Koina, M. E., McCuskey, R. S., Teoh, N. C., & Farrell, G. C. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.024 · Cited by 198
Relation of Nonalcoholic Hepatic Steatosis to Early Carotid Atherosclerosis in Healthy Men
Targher, G., Bertolini, L., Padovani, R., Zenari, L., Zoppini, G., & Falezza, G. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2498 · Cited by 197
Self-citationNonalcoholic fatty liver disease and vascular disease: State-of-the-art
Fargion, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i37.13306 · Cited by 196
Effects of nonalcoholic fatty liver disease on the development of metabolic disorders
Fan, J., Li, F., Cai, X., Peng, Y., Ao, Q., & Gao, Y. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04781.x · Cited by 193
Petta, S., Argano, C., Colomba, D., Cammà, C., Di Marco, V., Cabibi, D., Tuttolomondo, A., Marchesini, G., Pinto, A., Licata, G., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.030 · Cited by 193
Bonapace, S., Perseghin, G., Molon, G., Canali, G., Bertolini, L., Zoppini, G., Barbieri, E., & Targher, G. (2012) · Diabetes Care · doi:10.2337/dc11-1820 · Cited by 183
Self-citationYamazaki, H., Tsuboya, T., Tsuji, K., Dohke, M., & Maguchi, H. (2015) · Diabetes Care · doi:10.2337/dc15-0140 · Cited by 172
Mortality From Chronic Liver Diseases in Diabetes
Zoppini, G., Fedeli, U., Gennaro, N., Saugo, M., Targher, G., & Bonora, E. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.132 · Cited by 172
Self-citationRisk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?
Targher, G., Chonchol, M., Zoppini, G., Abaterusso, C., & Bonora, E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.007 · Cited by 171
Self-citationThe F ramingham risk score and heart disease in nonalcoholic fatty liver disease
Treeprasertsuk, S., Leverage, S., Adams, L. A., Lindor, K. D., Sauver, J. L. S., & Angulo, P. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02753.x · Cited by 171
Resolution of Fatty Liver and Risk of Incident Diabetes
Sung, K.-C., Wild, S. H., & Byrne, C. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1519 · Cited by 169
Bril, F., Sninsky, J. J., Baca, A. M., Superko, H. R., Portillo Sanchez, P., Biernacki, D., Maximos, M., Lomonaco, R., Orsak, B., Suman, A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3111 · Cited by 168
Dissociating fatty liver and diabetes
Sun, Z., & Lazar, M. A. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.09.005 · Cited by 163
Chang, Y., Jung, H.-S., Yun, K. E., Cho, J., Cho, Y. K., & Ryu, S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.349 · Cited by 163
Wong, V. W., Wong, G. L., Yeung, J. C., Fung, C. C. Y., Chan, J. K., Chang, Z. H., Kwan, C. T., Lam, H., Limquiaco, J. L., Chim, A. M., et al. (2015) · Hepatology · doi:10.1002/hep.28253 · Cited by 163
Sinn, D. H., Kang, D., Chang, Y., Ryu, S., Gu, S., Kim, H., Seong, D., Cho, S. J., Yi, B.-K., Park, H.-D., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-311854 · Cited by 163
Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease
Hallsworth, K., Hollingsworth, K. G., Thoma, C., Jakovljević, D. G., MacGowan, G. A., Anstee, Q. M., Taylor, R., Day, C. P., & Trenell, M. I. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.015 · Cited by 162
Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome
Wainwright, P., & Byrne, C. D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030367 · Cited by 162
Cheng, J. M., Suoniemi, M., Kardys, I., Vihervaara, T., de Boer, S. P. M., Akkerhuis, K. M., Sysi-Aho, M., Ekroos, K., Garcia-Garcia, H. M., Oemrawsingh, R. M., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.10.022 · Cited by 158
Park, S. K., Seo, M. H., Shin, H. C., & Ryoo, J.-H. (2013) · Hepatology · doi:10.1002/hep.26183 · Cited by 158
Ballestri, S., Nascimbeni, F., Romagnoli, D., & Lonardo, A. (2016) · Hepatology Research · doi:10.1111/hepr.12656 · Cited by 158
Self-citationSung, K., Wild, S. H., & Byrne, C. D. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.009 · Cited by 156
Hepatic steatosis and insulin resistance: Does etiology make a difference?
Lonardo, A., Lombardini, S., Scaglioni, F., Carulli, L., Ricchi, M., Ganazzi, D., Adinolfi, L. E., Ruggiero, G., Carulli, N., & Loria, P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.018 · Cited by 154
Self-citationPrognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
Jepsen, P., Vilstrup, H., Mellemkjær, L., Thulstrup, A. M., Olsen, J. H., Baron, J. A., & Sørensen, H. T. (2003) · PubMed · Cited by 152
Chen, S. C.-C., Tsai, S. P., Jhao, J.-Y., Jiang, W.-K., Tsao, C. K., & Chang, L.-Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-04631-7 · Cited by 148
Aneni, E. C., Oni, E., Martin, S. S., Blaha, M. J., Agatston, A. S., Feldman, T., Veledar, E., Conceição, R., Carvalho, J. A. M., Santos, R. D., et al. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000532 · Cited by 146
Stanton, M. C., Chen, S., Jackson, J. V., Rojas-Triana, A., Kinsley, D., Cui, L., Fine, J. S., Greenfeder, S. A., Bober, L. A., & Jenh, C. (2011) · Journal of Inflammation · doi:10.1186/1476-9255-8-8 · Cited by 145
Newly diagnosed diabetes mellitus as a risk factor for serious liver disease
Porepa, L. F., Ray, J. G., Sanchez-Romeu, P., & Booth, G. L. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.092144 · Cited by 142
Bae, J. C., Rhee, E., Lee, W., Park, S. E., Park, C., Oh, K. W., Park, S. W., & Kim, S. W. (2011) · Diabetes Care · doi:10.2337/dc10-1991 · Cited by 141
Clinical association between non‐alcoholic fatty liver disease and the development of hypertension
Ryoo, J., Suh, Y. J., Shin, H. C., Cho, Y. K., Choi, J., & Park, S. K. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12643 · Cited by 139
Sviklāne, L., Olmane, E., Dzērve, Z., Kupčs, K., Pīrāgs, V., & Sokolovska, J. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13814 · Cited by 139
Amaro, A., Fabbrini, E., Kars, M., Yue, P., Schechtman, K. B., Schonfeld, G., & Klein, S. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.039 · Cited by 135
Rooyen, D. M. V., Gan, L. T., Yeh, M. M., Haigh, W. G., Larter, C. Z., Ioannou, G. N., Teoh, N., & Farrell, G. C. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.024 · Cited by 128
Body Fat Distribution, Liver Enzymes, and Risk of Hypertension
Stranges, S., Trevisan, M., Dorn, J. M., Dmochowski, J., & Donahue, R. P. (2005) · Hypertension · doi:10.1161/01.hyp.0000185688.81320.4d · Cited by 120
Hashimoto, Y., Hamaguchi, M., Kojima, T., Fukuda, T., Ohbora, A., & Fukui, M. (2017) · Medicine · doi:10.1097/md.0000000000006712 · Cited by 116
Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease
Mantovani, A., Ballestri, S., Lonardo, A., & Targher, G. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4040-6 · Cited by 115
Self-citationPersistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis
Sinn, D. H., Cho, S. J., Gu, S., Seong, D., Kang, D., Kim, H., Yi, B.-K., Paik, S. W., Güallar, E., Cho, J., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.001 · Cited by 115
Dissociation betweenAPOC3variants, hepatic triglyceride content and insulin resistance
Kozlitina, J., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2010) · Hepatology · doi:10.1002/hep.24072 · Cited by 114
Park, J. Y., Lee, S., Shin, M., & Hwang, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135228 · Cited by 114
Sigala, B., McKee, C. M., Soeda, J., Pazienza, V., Morgan, M. L., Lin, C., Selden, C., Borght, S. V., Mazzoccoli, G., Roskams, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072928 · Cited by 113
Immune Cell Crosstalk in Obesity: A Key Role for Costimulation?
Seijkens, T. T. P., Kusters, P. J. H., Chatzigeorgiou, A., Chavakis, T., & Lutgens, E. (2014) · Diabetes · doi:10.2337/db14-0272 · Cited by 110
Brachial-Ankle Pulse Wave Velocity Predicts Increase in Blood Pressure and Onset of Hypertension
Takase, H., Dohi, Y., Toriyama, T., Okado, T., Tanaka, S., Sonoda, H., Sato, K., & Kimura, G. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.19 · Cited by 109
Kuwahara, F., Kai, H., Tokuda, K., Shibata, R., Kusaba, K., Tahara, N., Niiyama, H., Nagata, T., & Imaizumi, T. (2002) · Hypertension · doi:10.1161/hy1201.097200 · Cited by 106
The Role of Adiponectin in Endothelial Dysfunction and Hypertension
Rojas, E., Rodríguez-Molina, D., Bolli, P., Israili, Z. H., Faría, J., Fidilio, E., Bermúdez, V., & Velasco, M. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0463-7 · Cited by 106
Longitudinal Assessment of High Blood Pressure in Children with Nonalcoholic Fatty Liver Disease
Schwimmer, J. B., Zepeda, A., Newton, K. P., Xanthakos, S. A., Behling, C. A., Hallinan, E., Donithan, M., & Tonascia, J. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112569 · Cited by 106
Sookoian, S. C., Gianotti, T. F., Rosselli, M. S., Burgueño, A. L., Castaño, G. O., & Pirola, C. J. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.05.014 · Cited by 105
Pisto, P., Santaniemi, M., Bloigu, R., Ukkola, O. H., & Kesäniemi, Y. A. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004973 · Cited by 105
Coulon, S., Legry, V., Heindryckx, F., Steenkiste, C. V., Casteleyn, C. R., Olievier, K., Libbrecht, L. J., Carmeliet, P., Jonckx, B., Stassen, J., et al. (2013) · Hepatology · doi:10.1002/hep.26219 · Cited by 103
Nonalcoholic Fatty Liver Disease and Incident Cardiac Events
Zeb, I., Li, D., Budoff, M. J., Katz, R., Lloyd‐Jones, D. M., Agatston, A. A., Blumenthal, R. S., Blaha, M. J., Blankstein, R., Carr, J. J., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.070 · Cited by 101
Fatty liver incidence and predictive variables
Tsuneto, A., Hida, A., Sera, N., Imaizumi, M., Ichimaru, S., Nakashima, E., Seto, S., Maemura, K., & Akahoshi, M. (2010) · Hypertension Research · doi:10.1038/hr.2010.45 · Cited by 100
Fracanzani, A. L., Tiraboschi, S., Pisano, G., Consonni, D., Baragetti, A., Bertelli, C., Norata, G. D., Valenti, L. V. C., Grigore, L., Porzio, M., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.01.016 · Cited by 99
Hepatokines as a Link between Obesity and Cardiovascular Diseases
Yoo, H. J., & Choi, K. M. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.1.10 · Cited by 98
Targher, G., Marchesini, G., & Byrne, C. D. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.04.002 · Cited by 97
Self-citationLong, M. T., Wang, N., Larson, M. G., Mitchell, G. F., Palmisano, J. N., Vasan, R. S., Hoffmann, U., Speliotes, E. K., Vita, J. A., Benjamin, E. J., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.305200 · Cited by 94
A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study
Huh, J. H., Ahn, S. V., Koh, S. B., Choi, E. H., Kim, J., Sung, K., Kim, E. J., & Park, J. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143560 · Cited by 93
Sorrentino, P., Terracciano, L., D’Angelo, S., Ferbo, U., Bracigliano, A., & Vecchione, R. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.587 · Cited by 92
Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease
Lonardo, A., Ballestri, S., Targher, G., & Loria, P. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.965143 · Cited by 88
Self-citationYoneda, M., Hotta, K., Nozaki, Y., Endo, H., Uchiyama, T., Mawatari, H., Iida, H., Kato, S., Fujita, K., Takahashi, H., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.01988.x · Cited by 87
Type 2 diabetes and risk of hospital admission or death for chronic liver diseases
Wild, S. H., Morling, J. R., McAllister, D., Kerssens, J., Fischbacher, C., Parkes, J., Roderick, P. J., Sattar, N. A., & Byrne, C. D. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.014 · Cited by 84
Lorbeer, R., Bayerl, C., Auweter, S., Rospleszcz, S., Lieb, W., Meisinger, C., Heier, M., Peters, A., Bamberg, F., & Hetterich, H. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001245 · Cited by 84
Pelusi, S., Petta, S., Rosso, C., Borroni, V. N., Fracanzani, A. L., Dongiovanni, P., Craxì, A., Bugianesi, E., Fargion, S. R., & Valenti, L. V. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163069 · Cited by 83
Mantovani, A., Mingolla, L., Rigolon, R., Pichiri, I., Cavalieri, V., Zoppini, G., Lippi, G., Bonora, E., & Targher, G. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.10.040 · Cited by 82
Self-citationErridge, C. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.02.043 · Cited by 82
Zhang, Y., Zhang, T., Zhang, C., Tang, F., Zhong, N., Li, H., Song, X., Lin, H., Liu, Y., & Xue, F. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008204 · Cited by 81
Vorkas, P. A., Shalhoub, J., Isaac, G., Want, E. J., Nicholson, J. K., Holmes, E. C., & Davies, A. H. (2015) · Journal of Proteome Research · doi:10.1021/pr5009898 · Cited by 78
Bonnet, F., Gastaldelli, A., Bars, F. P., Natali, A., Roussel, R., Petrie, J. R., Tichet, J., Marre, M., Fromenty, B., & Balkau, B. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001204 · Cited by 78
Miyaaki, H., Ichikawa, T., Nakao, K., Yatsuhashi, H., FURUKAWA, R., Ohba, K., Omagari, K., KUSUMOTO, Y., Yanagi, K., INOUE, O., et al. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01614.x · Cited by 76
Lau, K., Lorbeer, R., Haring, R., Schmidt, C. O., Wallaschofski, H., Nauck, M. A., John, U., Baumeister, S. E., & Völzke, H. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833c211b · Cited by 76
Park, H. E., Kwak, M., Kim, D., Kim, M.-K., Cha, M., & Choi, S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1525 · Cited by 76
Arterial Stiffness as a Predictor of Clinical Hypertension
Zheng, X., Jin, C., Liu, Y., Zhang, J., Zhu, Y., Kan, S., Wu, Y., Ruan, C., Lin, L., Yang, X., et al. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12556 · Cited by 74
Li, Y., Wang, J., Tang, Y., Han, X., Liu, B., Hu, H., Li, X., Yang, K., Yuan, J., Miao, X., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174291 · Cited by 74
Zhang, T., Zhang, C., Zhang, Y., Tang, F., Li, H., Zhang, Q., Lin, H., Wu, S., Liu, Y., & Xue, F. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.02.049 · Cited by 73
Sato, M., Kamada, Y., Takeda, Y., Kida, S., Ohara, Y., Fujii, H., Akita, M., Mizutani, K., Yoshida, Y., Yamada, M., et al. (2014) · Liver International · doi:10.1111/liv.12478 · Cited by 72
Facilitatory effects of fetuin-A on atherosclerosis
Naito, C., Hashimoto, M., Watanabe, K., Shirai, R., Takahashi, Y., Kojima, M., Watanabe, R., Sato, K., Iso, Y., Matsuyama, T., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.01.037 · Cited by 65
Björkström, K., Stal, P. I., Hultcrantz, R. W., & Hagström, H. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.04.040 · Cited by 63
Sanyal, A. J., & Pacana, T. (2015) · Europe PMC (PubMed Central) · Cited by 59
Fatty liver, carotid disease and gallstones: A study of age-related associations
Lonardo, A., Lombardini, S., Scaglioni, F., Ballestri, S., Verrone, A.-M., Bertolotti, M., Carulli, L., Ganazzi, D., Carulli, N., & Loria, P. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i36.5826 · Cited by 58
Self-citationByrne, C. D., & Targher, G. (2013) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0033-1334866 · Cited by 58
Self-citationValbusa, F., Bonapace, S., Agnoletti, D., Scala, L., Grillo, C., Arduini, P., Turcato, E., Mantovani, A., Zoppini, G., Arcaro, G., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173398 · Cited by 58
Self-citationAzeem, H. A. E., Khalek, E.-S. A., El-Akabawy, H., Na'eim, H., Khalik, H. A., & Alfifi, A. A. (2013) · Journal of the Saudi Heart Association · doi:10.1016/j.jsha.2013.07.004 · Cited by 57
Green, C. L., Mitchell, S. E., Derous, D., Wang, Y., Chen, L., Han, J. J., Promislow, D., Lusseau, D., Douglas, A., & Speakman, J. R. (2017) · Aging Cell · doi:10.1111/acel.12570 · Cited by 56
Non-alcoholic fatty liver disease is associated with progression of arterial stiffness
Li, N., Zhang, G.-W., Zhang, J.-R., Jin, D., Li, Y., Liu, T., & Wang, R.-T. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.10.002 · Cited by 54
Lefere, S., de Velde, F. V., Devisscher, L., Bekaert, M., Raevens, S., Verhelst, X., Nieuwenhove, Y. V., Praet, M. M., Hoorens, A., Steenkiste, C. V., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.102 · Cited by 54
Harman, D. J., Kaye, P., Harris, R., Suzuki, A., Gazis, A., & Aithal, G. P. (2014) · Hepatology · doi:10.1002/hep.27098 · Cited by 51
Wu, S., Zou, H., Zhu, G., Wang, L., Zhang, Q., Shi, K., Han, J., Huang, W., Braddock, M., Chen, Y., et al. (2015) · Medicine · doi:10.1097/md.0000000000000842 · Cited by 46
Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease
Zelber‐Sagi, S., Azar, S., Nemirovski, A., Webb, M., Halpern, Z., Shibolet, O., & Tam, J. (2016) · Obesity · doi:10.1002/oby.21687 · Cited by 46
Hashimoto, Y., Hamaguchi, M., Fukuda, T., Ohbora, A., Kojima, T., & Fukui, M. (2017) · Endocrine · doi:10.1007/s12020-017-1313-6 · Cited by 46
Cannizzaro, L., Rossoni, G., Savi, F., Altomare, A., Marinello, C., Saethang, T., Carini, M., Payne, D. M., Pisitkun, T., Aldini, G., et al. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-016-0149-z · Cited by 38
Kim, J., Lee, W., Park, S. E., Park, C., Lee, W., Oh, K.-W., Park, S., & Rhee, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180118 · Cited by 38
Association between nonalcoholic fatty liver disease and carotid atherosclerosis: a meta-analysis.
Cai, J. X., Zhang, S., & Huang, W. (2015) · Europe PMC (PubMed Central) · Cited by 37
Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies
Takeuchi, M., Takino, J.-I., Sakasai-Sakai, A., Takata, T., Ueda, T., Tsutsumi, M., Hyogo, H., & Yamagishi, S.-I. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i12.880 · Cited by 37
Qian, L.-Y., Tu, J., Ding, Y., Pang, J., Che, X.-D., Zou, H., & Huang, D. (2016) · Medicine · doi:10.1097/md.0000000000004293 · Cited by 37
Lonardo, A., Ballestri, S., & Targher, G. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.01.008 · Cited by 37
Self-citationINSULIN‐INDUCED ENHANCEMENT OF UPTAKE OF NORADRENALINE IN ATRIAL STRIPS
Bhagat, B. D., Burke, W. J., & Dhalla, N. S. (1981) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1981.tb09975.x · Cited by 36
Namisaki, T., Noguchi, R., Moriya, K., Kitade, M., Aihara, Y., Douhara, A., Nishimura, N., Takeda, K., Okura, Y., Kawaratani, H., et al. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1104-x · Cited by 35
Kopprasch, S., Dheban, S., Schuhmann, K., Xu, A., Schulte, K., Simeonovic, C. J., Schwarz, P. E. H., Bornstein, S. R., Shevchenko, A., & Graessler, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164173 · Cited by 35
Moon, S. H., Noh, T. S., Cho, Y. S., Hong, S. P., Hyun, S. H., Choi, J. Y., Kim, B., & Lee, K.-H. (2014) · Angiology · doi:10.1177/0003319714537872 · Cited by 34
Clinical Significance of Non-Alcoholic Fatty Liver Disease as a Risk Factor for Prehypertension
Ryoo, J., Ham, W. T., Choi, J., Kang, M. A., An, S. H., Lee, J., Shin, H. C., & Park, S. K. (2014) · Journal of Korean Medical Science · doi:10.3346/jkms.2014.29.7.973 · Cited by 32
Moreno, M. U., Eirós, R., Gavira, J. J., Gallego, C., González, A., Ravassa, S., López, B., Beaumont, J., José, G. S., & Dı́ez, J. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.08.002 · Cited by 32
Cited by
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
Epidemiology of metabolic dysfunction-associated steatotic liver disease
Younossi, Z. M., Kalligeros, M., & Henry, L. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0431 · Cited by 960
The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments
Targher, G., Corey, K. E., Byrne, C. D., & Roden, M. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00448-y · Cited by 850
Self-citationTargher, G., Byrne, C. D., & Tilg, H. (2020) · Gut · doi:10.1136/gutjnl-2020-320622 · Cited by 827
Self-citationSGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
Cowie, M. R., & Fisher, M. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0406-8 · Cited by 784
Metadata
- Authors
- Lonardo, A., Nascimbeni, F., Mantovani, A., & Targher, G.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 68
- Issue
- 2
- Pages
- 335-352
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2767309773
- Cited by
- 736
- References
- 211
- FWCI
- 36.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.